In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: Implications for cellular therapy

Stem Cells

Volumn 26, Issue 5, 2008, Pages 1366-1375

  Pawelczyk, Edyta ^a,b   Arbab, Ali S ^c   Chaudhry, Aneeka ^b   Balakumaran, Arun ^d   Robey, Pamela G ^d   Frank, Joseph A ^b  

^a Building 10 ^*  (United States)

^b Clinical Center   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Activated macrophages; Bromodeoxyuridine; Cell labeling; Ferumoxides; Human bone marrow stromal cells; Protamine sulfate; Superparamagnetic iron oxide nanoparticles

Indexed keywords

BROXURIDINE; CD68 ANTIGEN; DEXTRAN; IRON; IRON OXIDE; NANOPARTICLE; OXIDE; PROTAMINE; SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; BONE MARROW CELL; CELL LABELING; CELL MIGRATION; CELL THERAPY; CELL VIABILITY; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; INFLAMMATORY CELL; IRON TRANSPORT; MACROPHAGE ACTIVATION; STEM CELL; STROMA CELL; ANIMAL; APOPTOSIS; BIOLOGICAL THERAPY; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; MACROPHAGE; METABOLISM; MOUSE; REPRODUCIBILITY; STAINING;

ANIMALS; APOPTOSIS; BROMODEOXYURIDINE; CELL SURVIVAL; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IRON; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NANOPARTICLES; OXIDES; PROTAMINES; REPRODUCIBILITY OF RESULTS; STAINING AND LABELING; STEM CELLS; TISSUE THERAPY;

EID: 47949083824     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0707     Document Type: Article

References (36)

1. Passweg J, Tyndall A. Autologous stem cell transplantation in autoimmune diseases. Semin Hematol 2007;44:278-285.
2. Pommey S, Galipeau J. The use of mesenchymal stromal cells in oncology and cell therapy [in French]. Bull Cancer 2006;93:901-907.
3. Christoforou N, Gearhart JD. Stem cells and their potential in cell-based cardiac therapies. Prog Cardiovasc Dis 2007;49:396-413.
4. Young PP, Vaughan DE, Hatzopoulos AK. Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis 2007;49:421-429.
5. Vilquin JT, Rosset P. Mesenchymal stem cells in bone and cartilage repair: Current status. Regen Med 2006;1:589-604.
6. Gratzner HG. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 1982;218:474-475.
7. Taupin P. Protocols for studying adult neurogenesis: Insights and recent developments. Regen Med 2007;2:51-62.
8. McConnell S. Migration and differentiation of cerebral cortical neurons after transplantation into the brains of ferrets. Science 1985;229:1268-1271.
9. Altman J, Das GD. Post-natal origin of microneurones in the rat brain. Nature 1965;207:953-956.
10. Flax JD, Aurora S, Yang C et al. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat Biotechnol 1998;16:1033-1039.
11. Lundberg C, Martinez-Serrano A, Cattaneo E et al. Survival, integration, and differentiation of neural stem cell lines after transplantation to the adult rat striatum. Exp Neurol 1997;145:342-360.
12. McDonald JW, Liu XZ, Qu Y et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 1999;5:1410-1412.
13. Arbab AS, Yocum GT, Kalish H et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004;104:1217-1223.
14. Arbab AS, Jordan EK, Wilson LB et al. In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum Gene Ther 2004;15:351-360.
15. Frank JA, Anderson SA, Kalsih H et al. Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging. Cytotherapy 2004;6:621-625.
16. Anderson SA, Shukaliak-Quandt J, Jordan EK et al. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol 2004;55:654-659.
17. Anderson SA, Glod J, Arbab AS et al. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 2005;105:420-425.
18. Arbab AS, Pandit SD, Anderson SA et al. Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis. STEM CELLS 2006;24:671-678.
19. Arbab AS, Yocum GT, Rad AM et al. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 2005;18:553-559.
20. Suzuki Y, Zhang S, Kundu P et al. In vitro comparison of the biological effects of three transfection methods for magnetically labeling mouse embryonic stem cells with ferumoxides. Magn Reson Med 2007;57:1173-1179.
21. Arbab AS, Rad AM, Iskander AS et al. Magnetically-labeled sensitized splenocytes to identify glioma by MRI: A preliminary study. Magn Reson Med 2007;58:519-526.
22. Burns TC, Ortiz-Gonzalez XR, Gutierrez-Perez M et al. Thymidine analogs are transferred from prelabeled donor to host cells in the central nervous system after transplantation: A word of caution. STEM CELLS 2006;24:1121-1127.
23. Rieck B, Schlaak S. Measurement in vivo of the survival rate in autologous adipocyte transplantation. Plast Reconstr Surg 2003;111:2315-2323.
24. Ebert SN, Taylor DG, Nguyen HL et al. Non-invasive tracking of cardiac embryonic stem cells in vivo using magnetic resonance imaging techniques. STEM CELLS 2007;25:2936-2944.
25. Coyne TM, Marcus AJ, Woodbury D et al. Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. STEM CELLS 2006;24:2483-2492.
26. Tallheden T, Nannmark U, Lorentzon M et al. In vivo MR imaging of magnetically labeled human embryonic stem cells. Life Sci 2006;79:999-1006.
27. Rogers WJ, Meyer CH, Kramer CM. Technology insight: In vivo cell tracking by use of MRI. Nat Clin Pract Cardiovasc Med 2006;3:554-562.
28. Lepore AC, Walczak P, Rao MS et al. MR imaging of lineage-restricted neural precursors following transplantation into the adult spinal cord. Exp Neurol 2006;201:49-59.
29. Cahill KS, Germain S, Byrne BJ et al. Non-invasive analysis of myoblast transplants in rodent cardiac muscle. Int J Cardiovasc Imaging 2004;20:593-598.
30. Molcanyi M, Riess P, Bentz K et al. Trauma-associated inflammatory response impairs embryonic stem cell survival and integration after implantation into injured rat brain. J Neurotrauma 2007;24:625- 637.
31. Bianco P, Kuznetsov SA, Riminucci M et al. Postnatal skeletal stem cells. Methods Enzymol 2006;419:117-148.
32. Kondziolka D, Steinberg GK, Cullen SB et al. Evaluation of surgical techniques for neuronal cell transplantation used in patients with stroke. Cell Transplant 2004;13:749-754.
33. Tukey JW. Some selected quick and easy methods of statistical analysis. Trans N Y Acad Sci 1953;16:88-97.
34. Brekke C, Williams SC, Price J et al. Cellular multiparametric MRI of neural stem cell therapy in a rat glioma model. Neuroimage 2007;37:769-782.
35. Rosen AB, Kelly DJ, Schuldt AJ et al. Finding fluorescent needles in the cardiac haystack: Tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. STEM CELLS 2007;25:2128 -2138.
36. Bourrinet P, Bengele HH, Bonnemain B et al. Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest Radiol 2006;41:313-324.